Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies

Traumatic brain injury is one of the leading cause of death and long term disability in virtually every country. Advances in neurointensive care have resulted in steadily decreasing morbidity, but the number of individuals with severe long term disability have not changed significantly and the numbe...

Full description

Bibliographic Details
Main Authors: Denes V Agoston, Bo-Michael eBellander, Mårten eRisling
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00003/full
id doaj-ab8951443c7d41ca84ec812229d8bb1d
record_format Article
spelling doaj-ab8951443c7d41ca84ec812229d8bb1d2020-11-24T22:20:54ZengFrontiers Media S.A.Frontiers in Neurology1664-22952012-02-01310.3389/fneur.2012.0000317705Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studiesDenes V Agoston0Denes V Agoston1Bo-Michael eBellander2Mårten eRisling3Uniformed Services University of the Health SciencesKarolinska InstitutetKarolinska University HospitalKarolinska InstitutetTraumatic brain injury is one of the leading cause of death and long term disability in virtually every country. Advances in neurointensive care have resulted in steadily decreasing morbidity, but the number of individuals with severe long term disability have not changed significantly and the number of moderate disability has shown steady increase over the last 3 decades. Despite years of intensive preclinical research - and millions spent - there are virtually no drugs specifically developed to mitigate the consequences of TBI. Here we discuss some of the existing gaps between clinical and experimental TBI studies that may have contributed to the current status. We do this hoping that clinical, basic, and translational scientists will design and coordinate studies in order to achieve maximum benefits for TBI patients. In conclusion, we suggest to: 1) Develop consensus based guidelines for experimental TBI research, similar to best practices in the clinic; 2) Generate a consensus-based template for clinical data collection and deposition as well as for experimental TBI data collection and deposition; 3) Use a systems biology approach and create a database for integrating existing data from basic and clinical research.http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00003/fullhumananimalclinicalexperimentalneurotraumagaps
collection DOAJ
language English
format Article
sources DOAJ
author Denes V Agoston
Denes V Agoston
Bo-Michael eBellander
Mårten eRisling
spellingShingle Denes V Agoston
Denes V Agoston
Bo-Michael eBellander
Mårten eRisling
Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
Frontiers in Neurology
human
animal
clinical
experimental
neurotrauma
gaps
author_facet Denes V Agoston
Denes V Agoston
Bo-Michael eBellander
Mårten eRisling
author_sort Denes V Agoston
title Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
title_short Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
title_full Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
title_fullStr Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
title_full_unstemmed Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
title_sort bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2012-02-01
description Traumatic brain injury is one of the leading cause of death and long term disability in virtually every country. Advances in neurointensive care have resulted in steadily decreasing morbidity, but the number of individuals with severe long term disability have not changed significantly and the number of moderate disability has shown steady increase over the last 3 decades. Despite years of intensive preclinical research - and millions spent - there are virtually no drugs specifically developed to mitigate the consequences of TBI. Here we discuss some of the existing gaps between clinical and experimental TBI studies that may have contributed to the current status. We do this hoping that clinical, basic, and translational scientists will design and coordinate studies in order to achieve maximum benefits for TBI patients. In conclusion, we suggest to: 1) Develop consensus based guidelines for experimental TBI research, similar to best practices in the clinic; 2) Generate a consensus-based template for clinical data collection and deposition as well as for experimental TBI data collection and deposition; 3) Use a systems biology approach and create a database for integrating existing data from basic and clinical research.
topic human
animal
clinical
experimental
neurotrauma
gaps
url http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00003/full
work_keys_str_mv AT denesvagoston benchtobedsideandbedsidebacktothebenchcoordinatingclinicalandexperimentaltraumaticbraininjurystudies
AT denesvagoston benchtobedsideandbedsidebacktothebenchcoordinatingclinicalandexperimentaltraumaticbraininjurystudies
AT bomichaelebellander benchtobedsideandbedsidebacktothebenchcoordinatingclinicalandexperimentaltraumaticbraininjurystudies
AT martenerisling benchtobedsideandbedsidebacktothebenchcoordinatingclinicalandexperimentaltraumaticbraininjurystudies
_version_ 1725773280767377408